IBR2 is a specific RAD51 inhibitor that disrupts RAD51 multimerization and promotes its proteasomal degradation, thereby suppressing homologous recombination repair. This compound inhibits cancer cell proliferation and induces apoptosis, making it a valuable tool for studying DNA repair mechanisms in cancer research, both in vitro and in vivo.
